Stay updated on Safety of Growth Hormone-Deficiency Treatment Clinical Trial
Sign up to get notified when there's something new on the Safety of Growth Hormone-Deficiency Treatment Clinical Trial page.

Latest updates to the Safety of Growth Hormone-Deficiency Treatment Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 deployed; the visible content and layout of the study page appear unchanged. To minimize alerts for minor changes, consider configuring an alert condition.SummaryDifference0.0%

- Check21 days agoChange DetectedOnly the revision label updated from v3.4.0 to v3.4.1; the visible study details and page layout remain unchanged.SummaryDifference0.0%

- Check28 days agoChange DetectedThe changes add a glossary toggle and new QC-related metadata labels ('Last Update Submitted that Met QC Criteria', 'Revision: v3.4.0'), and remove older QC labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page header — No study data or content has changed, and the update is limited to metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (California, Colorado, Delaware, Florida, Michigan, Nevada, New York, North Carolina, Pennsylvania, Texas, Virginia, Washington) with a revision tag v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check92 days agoChange DetectedRevision label updated to v3.3.2 (previously v3.2.0). This is a minor maintenance update with no changes to the study content.SummaryDifference0.0%

Stay in the know with updates to Safety of Growth Hormone-Deficiency Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Growth Hormone-Deficiency Treatment Clinical Trial page.